15. •AKI & CVP, CI, systolic BP, & PCWP
Mullens et al. JACC 2009
CVP
CI
PCWPSBP
16. •AKI & CVP, CI, systolic BP, & PCWP
Mullens et al. JACC 2009
CVP
CI
PCWPSBP
17. •Volume and outcome in AKI-RRT
0%
10%
20%
30%
40%
50%
60%
70%
<0 0-5 5-10 10-15 >15
90-dmortality
Fluid accumulation (% of body weight)
Bouchard et al. KI 2009, Payen et al. Crit Care 2008,
Grams et al. CJASN 2011, Vaara et al. Crit Care 2012
21. •Summary Recent PRCT’s HES
Study N Survival
AKI Other side effects
Magder, CABG
10% HES 250/0,5
262 Less Better HD
FIRST, trauma
6% HES 130/0,4
67 P
42 B
Less
Same
Better lactate
More blood
CRYSTMAS severe sepsis
6% HES 130/0,4
196 Same
6S severe sepsis
6% HES 130/0,42
798 Worse More More blood
CHEST ICU
6% HES 130/0,4
7000 Same More Liver, pruritus, blood
products
Magder et al Crit Care Med 2010, James et al. J Trauma 2011, Guidet et al.
Crit Care 2012, Perner et al. NEJM 2012, Myburgh et al. NEJM 2012
22. •AKI after gelatin
Schabinski et al. Intensive Care Med 2009
Observational
N = 1383 HES
N = 1528 GEL
MVR adjusted Risk for AKI after >33mL/kg
GEL: OR 1.99 (1.05-3.79)
HES: OR 1.85 (1.01 – 3.41)
23. •PRCT’s on albumin
n Survival
AKI Bleeding/coag
ulation
SAFE 6997 Same More PC
SAFE TBI 460 Worse More PC
FEAST sepsis 3141 Worse
SAFE severe sepsis 1218 No diff (trend) No diff No diff
CRYSTMAS severe sepsis 196 No diff No diff
EARSS severe sepsis 792 No diff No diff
ALBIOS severe sepsis 1818 No diff No diff No diff
24. •Saline vs. Plasmalyte ®?
Shaw et al. Ann Surg 2012
Saline = More complications and use of resources:
Major infection
Dialysis
Blood transfusions
Electrolyte disturbances
N = 30,994 vs. 926
Major abd surgery